LEEI Consortium
A new generation of vaccine manufacturing is rising
7
Years of experience
3
Partners
1
Aim
The „LEEI Consortium“ is an interdisciplinary collaboration between the various partners of KyooBe Tech, Bausch+Ströbel and four Fraunhofer Research Institutes.
We use, in a new and innovative approach, electron beams instead of toxic chemicals for pathogen inactivation. This increases time-efficiency of production, vaccine quality and process reproducibility.

Thanks to the interdisciplinary structure of the team, KyooBe Tech can further advance process-oriented optimization and system integration as well as market adaptation for customers.
Bausch+Ströbel is a trusted and experienced supplier to the pharmaceutical industry specializing in filling and packaging systems.
B+S‘s expertise in the development and manufacture of high-precision machines for pharmaceutical production forms an important basis for the high quality standards that apply to pharmaceuticals such as Vaccines.
A group of four Fraunhofer institutes are scientific pioneers for this technology. They contiously develop and elaborate new fields of application of LEEI-technologies. They conduct extensive studies on pathogenes to develop future vaccine candidates. The Fraunhofer institutes are in charge of the prototype system.
Since 2014, they have been developing the foundations for patented technology and scientific evidence for its effectiveness in various applications.
In addition, the Bill & Melinda Gates Foundation invested USD 1.85 million for the second phase of the technology roadmap.
Our journey
Parcipitate in a new generation of vacccine manufacturing!
Get in contact to learn and participate!